50
Views
0
CrossRef citations to date
0
Altmetric
Review

Postoperative complications in ophthalmic plastic and reconstructive surgery

, &
Pages 1001-1018 | Published online: 09 Jan 2014

References

  • Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N. Engl. J. Med.336(21), 1506–1511 (1997).
  • Custer PL, Trinkaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal. Plast. Reconstr. Surg.18(6), 409–415 (2002).
  • Gainey SP, Robertson DM, Fay W, Ilstrup D Ocular surgery on patients receiving long-term warfarin therapy. Am. J. Ophthalmol.108(2), 142–146 (1989).
  • Jonas JB, Pakdaman B, Sauder G. Cataract surgery under systemic anticoagulant therapy with coumarin. Eur. J. Ophthalmol.16(1), 30–32 (2006).
  • Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin. Experiment Ophthalmol.28(6), 419–422 (2000).
  • Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br. J. Plast. Surg.52(3), 214–216 (1999).
  • Larson BJ, Zumberg MS, Kitchen CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest127(3) 922–927 (2005).
  • Putterman AM, Urist MJ. Müller’s muscle-conjunctival resection ptosis procedure. Ophthalmic. Surg.9(3), 27–32 (1978).
  • Dresner S. Ptosis management: a practical approach. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme, NY, USA 75–88 (2001).
  • Shields M, Putterman A. Blepharoptosis correction. Curr. Opin. Otolaryngol. Head Neck Surg.11(4), 261–266 (2003).
  • Baldwin HC, Bhagey J, Khooshabeh R. Open sky Müller muscle-conjunctival resection in phenylephrine test-negative blepharoptosis patients. Ophthal. Plast. Reconstr. Surg.21(4), 276–280 (2005).
  • Fasanella RM, Servat J. Levator resection for minimal ptosis: another simplified operation. Arch. Ophthalmol.65, 493–496 (1961).
  • Mercandetti M, Putterman AM, Cohen ME, Mirante JP, Cohen AJ. Internal levator advancement by Müller’s muscle-conjunctival resection: technique and review. Arch. Facial Plast. Surg.3(2), 104–110 (2001).
  • Ben Simon GJ, Lee S, Schwarcz RM, McCann JD, Goldberg RA. External levator advancement vs Muller's muscle-conjunctival resection for correction of upper eyelid involutional ptosis. Am. J. Ophthalmol.140(3), 426–432 (2005).
  • Foster JA, Holck DE, Perry JD et al. Fibrin sealant for Müller muscle-conjunctiva resection ptosis repair. Ophthal. Plast. Reconstr. Surg.22(3), 184–187 (2006).
  • Sierra CA, Gladstone GJ. Muller’s muscle-conjunctival resection. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 91–102 (2003).
  • Weinstein GS, Buerger GF. Modification of the Müller's muscle-conjunctival resection operation for blepharoptosis. Am. J. Ophthalmol.93(5), 647–651 (1982).
  • Guyuron B, Davies B. Experience with the modified Putterman procedure. Plast. Reconstr. Surg.82(5), 775–780 (1988).
  • Brown MS, Putterman AM. The effect of upper blepharoplasty on eyelid position when performed concomitantly with Müller muscle-conjunctival resection. Ophthal. Plast. Reconstr. Surg.16(2), 94–100 (2000).
  • Dailey RA, Saulny SM, Sullivan SA. Müller muscle-conjunctival resection: effect on tear production. Ophthal. Plast. Reconstr. Surg.18(6), 421–425 (2002).
  • Lucarella MJ, Cook BE, Lemke BN. Small-incision external levator repair. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 103–114 (2003).
  • Custer PL. Ptosis: levator muscle surgery and frontalis suspension. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme, NY, USA 89–102 (2001).
  • Bartley GB, Lowry JC, Hodge DO. Results of levator-advancement blepharoptosis repair using a standard protocol: effect of epinephrine induced eyelid position change. Trans. Am. Ophthamol. Soc.94, 165–175 (1996).
  • Takahashi Y, Kakizaki H, Mito H, Shiraki K. Assessment of predictive value of intraoperative eyelid height measurements in sitting and supine positions during blepharoptosis repair. Ophthal. Plast. Reconstr. Surg.23(2), 119–121 (2007).
  • McCulley TJ, Kersten RC, Kulwin DR, Feuer WJ. Outcome and influencing factors of external levator palpebrae superioris aponeurosis advancement for blepharoptosis. Ophthal. Plast. Reconstr. Surg.19(5), 388–393 (2003).
  • Frueh BR, Musch DC, McDonald HM. Efficacy and efficiency of a small-incision, minimal dissection procedure versus a traditional approach for correcting aponeurotic ptosis. Ophthalmology111(12), 2158–2163 (2004).
  • Wasserman BN, Sprunger DT, Helveston EM. Comparison of materials used in frontalis suspension. Arch. Ophthalmol.119(5), 687–691 (2001).
  • Goldey SH, Baylis HI, Goldberg RA, Shorr N. Frontalis muscle flap advancement for correction of blepharoptosis. Ophthal. Plast. Reconstr. Surg.16(2), 83–93 (2000).
  • Ben Simon GJ, Macedo AA, Schwarcz RM, Wang DY, McCann JD, Goldberg RA. Frontalis suspension for upper eyelid ptosis: evaluation of different surgical designs and suture material. Am. J. Ophthalmol.140(5), 877–885 (2005).
  • Bajaj MS, Sastry SS, Ghose S, Betharia SM, Pushker N. Evaluation of polytetrafluoroethylene suture for frontalis suspension as compared to polybutylate-coated braided polyester. Clin. Experiment Ophthalmol.32(4), 415–419 (2004).
  • Katowitz JA. Frontalis suspension in congenital ptosis using a polyfilament, cable-type suture. Arch. Ophthalmol.97(9), 1659–1663 (1979).
  • Leibovitch I, Leibovitch L, Dray JP. Long-term results of frontalis suspension using autogenous fascia lata for congenital ptosis in children under 3 years of age. Am. J. Ophthalmol.136(5), 866–871 (2003).
  • Carter SR, Meechan WJ, Seiff SR. Silicone frontalis slings for the correction of blepharoptosis: indications and efficacy. Ophthalmology103(4), 623–630 (1996).
  • Wilson ME, Johnson RW. Congenital ptosis. Long-term results of treatment using lyophilized fascia lata for frontalis suspensions Ophthalmology98(8), 1234–1237 (1991).
  • Kohn R. Textbook of ophthalmic plastic and reconstructive surgery. Lea and Febiger, PA, USA 98–131 (1988).
  • Sierra CA, Nesi FA. External 2003 elevator advancement. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 77–90 (2003).
  • Dubiel WT, Wigren A. Functional status of the lower extremity after resection of fascia lata. A clinical and physiological follow-up study in patients with fascia lata heart valve replacement. Acta Orthop. Scand.45(4), 599–613 (1974).
  • Wheatcroft SM, Vardy SJ, Tyers AG. Complications of fascia lata harvesting for ptosis surgery. Br. J. Ophthalmol.81(7), 581–583. (1997).
  • Mehta P, Patel P, Olver JM. Management of Mersilene mesh chronic eyelid complications: a systematic approach. Eye18(6), 640–642 (2004).
  • Frueh BR, Schoengarth LD. Evaluation and treatment of the patient with ectropion. Ophthalmology89(9), 1049–1054 (1982).
  • Neuhaus RW. Anatomical basis of “senile” ectropion. Ophthal. Plast. Reconstr. Surg.1(2), 87–89 (1985).
  • Bashour M, Harvey J. Causes of involutional ectropion and entropion – age-related tarsal changes are the key. Ophthal. Plast. Reconstr. Surg.16(2), 131–141 (2000).
  • Hegde V, Robinson R, Dean F, Mulvihill HA, Ahluwalia H. Drug-induced ectropion: what is best practice? Ophthalmology114(2), 362–366 (2007).
  • Nesi FA, Gladstone GJ, Brazzo BG, Myint S, Black EH. Ophthalmic and facial plastic surgery: a compendium of reconstructive and aesthetic techniques. Slack, NJ, USA 83–89 (2001).
  • Ben Simon GJ, Lee S, Schwarcz RM, McCann JD, Goldberg RA. Subperiosteal midface lift with or without a hard palate mucosal graft for correction of lower eyelid retraction. Ophthalmology113(10), 1869–1873 (2006).
  • Buerger DE. Ectropion. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 77–90 (2003).
  • Erb MH, Uzcategui N, Dresner SC. Efficacy and complications of the transconjunctival entropion repair for lower eyelid involutional entropion. Ophthalmology113(12), 2351–2356 (2006).
  • Liu D. Lower eyelid tightening: a comparative study. Ophthal. Plast. Reconstr. Surg.13(3), 199–203 (1997).
  • Dalgleish R, Smith JL. Mechanics and histology of senile entropion. Br. J. Ophthalmol.50(2), 79–91 (1966).
  • Jones LT. The anatomy of the lower eyelid and its relation to the cause and cure of entropion. Am. J. Ophthalmol.49, 29–36 (1960).
  • Dryden RM, Leibsohn J, Wobig J. Senile entropion. Pathogenesis and treatment. Arch Ophthalmol.96(10), 1883–1885 (1978).
  • Huang TT, Amayo E, Lewis SR. A histological study of the lower tarsus and the significance in the surgical management of a involutional (senile) entropion. Plast. Reconstr. Surg.67(5), 585–590 (1981).
  • Dresner SC, Karesh JW. Transconjunctival entropion repair. Arch. Ophthalmol.111(8), 1144–1148. (1993).
  • Onofrey CB, Tse DT. Entropion. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 41–53 (2003).
  • Rougraff PM, Tse DT, Johnson TE, Feuer W. Involutional entropion repair with fornix sutures and lateral tarsal strip procedure. Ophthal. Plast. Reconstr. Surg.17(4), 281–287 (2001).
  • Danks JJ, Rose GE. Involutional lower lid entropion: to shorten or not to shorten? Ophthalmology.105(11), 2065–2067 (1998).
  • Barnes JA, Bunce C, Olver JM. Simple effective surgery for involutional entropion suitable for the general ophthalmologist. Ophthalmology.113(1), 92–96 (2006).
  • Ho SF, Pherwani A, Elsherbiny SM, Reuser T. Lateral tarsal strip and quickert sutures for lower eyelid entropion. Ophthal. Plast. Reconstr. Surg.21(5), 345–348 (2005).
  • Boboridis K, Bunce C, Rose GE. A comparative study of two procedures for repair of involutional lower lid entropion. Ophthalmology107(5), 959–961 (2000).
  • Ben Simon GJ, Molina M, Schwarcz RM, McCann JD, Goldberg RA. External (subciliary) vs internal (transconjunctival) involutional entropion repair. Am. J. Ophthalmol.139(3), 482–487 (2005).
  • Erb MH, Dresner SC. External (subciliary) vs internal (transconjunctival) involutional entropion repair. Am. J. Ophthalmol.140(6), 1166–1167 (2005).
  • Khan SJ, Meyer DR. Transconjunctival lower eyelid involutional entropion repair: long-term follow-up and efficacy. Ophthalmology109(11), 2112–2117 (2002).
  • Tse DT, Neff AG. Ectropion. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme, NY, USA 55–65 (2001).
  • Goldberg RA, Joshi AR, McCann JD, Shorr N. Management of severe cicatricial entropion using shared mucosal grafts. Arch. Ophthalmol.117(9), 1255–1259 (1999).
  • Kersten RC, Kleiner FP, Kulwin DR. Tarsotomy for the treatment of cicatricial entropion with trichiasis. Arch. Ophthalmol.110(5), 714–717 (1992).
  • Millman AL, Katzen LB, Putterman AM. Cicatricial entropion: an analysis of its treatment with transverse blepharotomy and marginal rotation. Ophthalmic. Surg.20(8), 575–579 (1989).
  • Bercovici E, Hornblass A, Smith B. Cicatricial entropion. Ophthalmic. Surg.8(2), 112–125 (1977).
  • Seiff SR, Carter SR, Tovilla Y, Canales JL, Choo PH. Tarsal margin rotation with posterior lamella superadvancement for the management of cicatricial entropion of the upper eyelid. Am. J. Ophthalmol.127(1), 67–71 (1999).
  • Ti SE, Tow SL, Chee SP. Amniotic membrane transplantation in entropion surgery. Ophthalmology108(7), 1209–1217 (2001).
  • Kronish JW. Entropion. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme, NY USA 41–54 (2001).
  • Custer PL. Eyelid fistula following Wies entropion repair. Ophthalmic. Surg.19(6), 417–418 (1988).
  • Baylis HI, Nelson ER, Goldberg RA. Lower eyelid retraction following blepharoplasty. Ophthal. Plast. Reconstr. Surg.8(3), 170–175 (1992).
  • Stangler RA. Eyelid retraction. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA, 171–185 (2003).
  • Li TG, Shorr N, Goldberg RA. Comparison of the efficacy of hard palate grafts with acellular human dermis grafts in lower eyelid surgery. Plast. Reconstr. Surg.116(3), 873–880 (2005).
  • Patel BC, Patipa M, Anderson RL, McLeish W. Management of postblepharoplasty lower eyelid retraction with hard palate grafts and lateral tarsal strip. Plast. Reconstr. Surg.99(5), 1251–1260 (1997).
  • Feldman KA, Putterman AM, Farber MD. Surgical treatment of thyroid-related lower eyelid retraction: a modified approach. Ophthal. Plast. Reconstr. Surg.8(4), 278–286 (1992).
  • Verity DH, Collin JR. Eyelid reconstruction: the state of the art. Curr. Opin. Otolaryngol. Head Neck Surg.12(4), 344–348 (2004).
  • Aldave AJ, Maus M, Rubin PA. Advances in the management of lower eyelid retraction. Facial Plast. Surg.15(3), 213–224 (1999).
  • Shih MJ, Liao SL, Kuo KT, Smith TJ, Chuang LM. Molecular pathology of Muller’s muscle in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab.91(3), 1159–1167 (2006).
  • Putterman AM, Fett DR. Müller’s muscle in the treatment of upper eyelid retraction: a 12-year study. Ophthalmic. Surg.17(6), 361–367 (1986).
  • Wearne MJ, Sandy C, Rose GE, Pitts J, Collin JR. Autogenous hard palate mucosa: the ideal lower eyelid spacer? Br. J. Ophthalmol.85(10), 1183–1187 (2001).
  • Chang EL, Rubin PA. Upper and lower eyelid retraction. Int Ophthalmol Clin. Ing42(2), 45–59 (2002).
  • Fenton S, Kemp EG. A review of the outcome of upper lid lowering for eyelid retraction and complications of spacers at a single unit over five years. Orbit21(4), 289–294 (2002).
  • Airan LE, Born TM. Nonsurgical lower eyelid lift. Plast. Reconstr. Surg.116(6), 1785–1792 (2005).
  • Goldberg RA, Lee S, Jayasundera T, Tsirbas A, Douglas R, McCann JD. Treatment of lower eyelid retraction by expansion of the lower lid with hyaluronic acid gel. Ophthal. Plast. Reconstr. Surg.23(5), 343–348 (2007).
  • Small RG. Surgery for upper eyelid retraction, three techniques. Trans. Am. Ophthalmol. Soc.93, 353–369 (1995).
  • Morax S, Touitou V. Complications of blepharoplasty. Orbit25(4), 303–318 (2006).
  • Rohrich RJ, Coberly DM, Fagien S, Stuzin JM. Current concepts in aesthetic upper blepharoplasty. Plast. Reconstr. Surg.113(3), 32e–42e (2004).
  • Shorr N, Goldberg RA, McCann JD, Hoenig JA, Li TG. Upper eyelid skin grafting: an effective treatment for lagophthalmos following blepharoplasty. Plast. Reconstr. Surg.112(5), 1444–1448 (2003).
  • Khan JA. Upper blepharoplasty. Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 3–14 (2003).
  • Baylis HI, Sutcliffe T, Fett DR. Levator injury during blepharoplasty. Arch Ophthalmol.102(4), 570–571 (1984).
  • Harley RD, Nelson LB, Flanagan JC, Calhoun JH. Ocular motility disturbances following cosmetic blepharoplasty. Arch Ophthalmol.104(4), 542–544 (1986).
  • Ghabrial R, Lisman RD, Kane MA, Milite J, Richards R. Diplopia following transconjunctival blepharoplasty. Plast. Reconstr. Surg.102(4), 1219–1225 (1998).
  • Syniuta LA, Goldberg RA, Thacker NM, Rosenbaum AL. Acquired strabismus following cosmetic blepharoplasty. Plast. Reconstr. Surg.111(6), 2053–2059 (2003).
  • Wolfort FG, Poblete JV. Ptosis after blepharoplasty. Ann. Plast. Surg.34(3), 264–266 (1995).
  • DeMere M, Wood T, Austin W. Eye complications with blepharoplasty or other eyelid surgery. A national survey. Plast. Reconstr. Surg.53(6), 634–637 (1974).
  • Wolfort FG, Vaughan TE, Wolfort SF, Nevarre DR. Retrobulbar hematoma and blepharoplasty. Plast. Reconstr. Surg.104(7), 2154–2162 (1999).
  • McCord CD, Shore JW. Avoidance of complications in lower lid blepharoplasty. Ophthalmology90(9), 1039–1046 (1983).
  • Netscher DT, Patrinely JR, Peltier M, Polsen C, Thornby J. Transconjunctival versus transcutaneous lower eyelid blepharoplasty: a prospective study. Plast. Reconstr. Surg.96(5), 1053–1060 (1995).
  • Linberg JV, Anderson RL, Bumsted RM, Barreras R. Study of intranasal ostium external dacryocystorhinostomy. Arch Ophthalmol.100(11), 1758–1762 (1982).
  • Deka A, Bhattacharjee K, Bhuyan SK, Barua CK, Bhattacharjee H, Khaund G. Effect of mitomycin C on ostium in dacryocystorhinostomy. Clin. Experiment Ophthalmol.34(6), 557–561 (2006).
  • Liao SL, Kao SC, Tseng JH, Chen MS, Hou PK. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br. J. Ophthalmol.84(8), 903–906 (2000).
  • You YA, Fang CT. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthal. Plast. Reconstr. Surg.17(2), 115–119 (2001).
  • Yildirim C, Yaylali V, Esme A, Ozden S. Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int. Ophthalmol.27(1), 31–35 (2007).
  • Zileliolu G, Uğurbaş SH, Anadolu Y, Akiner M, Aktürk T. Adjunctive use of mitomycin C on endoscopic lacrimal surgery. Br. J. Ophthalmol.82(1), 63–66 (1998).
  • Warren JF, Seiff SR, Kavanagh MC. Long-term results of external dacryocystorhinostomy. Ophthalmic Surg. Lasers Imaging36(6), 446–450 (2005).
  • Tarbet KJ, Custer PL. External dacryocystorhinostomy. Surgical success, patient satisfaction, and economic cost. Ophthalmology102(7), 1065–1070 (1995).
  • Hartikainen J, Antila J, Varpula M, Puukka P, Seppa H, Grenman R. Prospective randomized comparison of endonasal endoscopic dacryocystorhinostomy and external dacryocystorhinostomy. Laryngoscope108(12), 1861–1866 (1998).
  • Hartikainen J, Grenman R, Puukka P, Seppa H. Prospective randomized comparison of external dacryocystorhinostomy and endonasal laser dacryocystorhinostomy. Ophthalmology105(6), 1106–1113. (1998).
  • Tsirbas A, Davis G, Wormald PJ. Mechanical endonasal dacryocystorhinostomy versus external dacryocystorhinostomy. Ophthal. Plast. Reconstr. Surg.20(1), 50–56 (2004).
  • Dolman PJ. Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology110(1), 78–84 (2003).
  • Wormwald PJ. Powered endoscopic dacryocystorhinostomy. Laryngoscope.112(1), 69–72 (2002).
  • Cokkeser Y, Evereklioglu C, Er H. Comparative external versus endoscopic dacryocystorhinostomy: results in 115 patients (130 eyes). Otolaryngol. Head Neck Surg.123(4), 488–491 (2000).
  • Tsirbas A, Wormald PJ. Endonasal dacryocystorhinostomy with mucosal flaps. Am. J. Ophthalmol.135(1), 76–83 (2003).
  • Hong JE, Hatton MP, Leib ML, Fay AM. Endocanalicular laser dacryocystorhinostomy analysis of 118 consecutive surgeries. Ophthalmology112(9), 1629–1633 (2005).
  • Woog JJ, Kennedy RH, Custer PL, Kaltreider SA, Meyer DR, Camara JG. Endonasal dacryocystorhinostomy: a report by the Am. Acad. Opthalmol.108(12), 2369–2377 (2001).
  • Buchan J, Cazabon SJ, Morrell AJ, Woodhead J. Learning curve in endonasal dacryocystorhinostomy. Am. J. Ophthalmol.136(3), 579–580 (2003).
  • Cook BE, Lucarelli MJ, Lemke BN. External dacryocystorhinostomy. Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 215–232 (2003).
  • Smith W, Merkonidis C, Yung M. Endoscopic dacryocystorhinostomy in patients taking aspirin perioperatively. Am. J. Otolaryngol. (5), 323–326 (2006).
  • Tsirbas A, McNab AA. Secondary haemorrhage after dacryocystorhinostomy. Clin. Experiment Ophthalmol.28(1), 22–25 (2000).
  • Ben Simon G, Cheung, McNab A. Personal communication. July 2007.
  • Sprekelsen MB, Barberan MT. Endoscopic dacryocystorhinostomy: surgical technique and results. Laryngoscope106, 187–189 (1996).
  • Watters GWR, Whittet HB, Shun-Shin GA, Milford CA. Endoscopic transnasal dacryocystorhinostomy- long-term results. Minim. Invasive Ther. Allied Technol.5, 505–510 (1996).
  • Fayet B, Racy E, Assouline M. Cerebrospinal fluid leakage after endonasal dacryocystorhinostomy. J. Fr. Ophthalmol.30(2), 129–134 (2007).
  • Migliori ME. Endoscopic evaluation and management of the lacrimal sump syndrome. Ophthal. Plast. Reconstr. Surg.13(4), 281–284 (1997).
  • Hughes AJ. Botulinum toxin in clinical practice. Drugs48(6), 888–893 (1994).
  • Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J. Am. Acad. Dermatol.53(3), 407–415 (2005).
  • Yoshimura DM, Aminoff MJ, Tami TA, Scott AB.Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve15(9), 1045–1049 (1992).
  • Lennerstrand G, Nordbø OA, Tian S, Eriksson-Derouet B, Ali T. of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol. Scand.76(1), 27–27 (1998).
  • Crouch ER. Use of botulism toxin in strabismus. Curr. Opin. Ophthalmol.17(5), 435–440 (2006).
  • Ben Simon GJ, McCann JD. Benign essential blepharospasm. Int. Ophthalmol. Clinic.45(3), 49–75 (2005).
  • Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J. Clin. Neurosci.7(5), 389–94 (2000).
  • Bell MS, Vermeulen LC, Sperling KB. Pharmacotherapy with botulinum toxin: harnessing nature’s most potent neurotoxin. Pharmacotherapy20(9), 1079–1091 (2000).
  • Morgenstern KE, Foster JA. Advances in cosmetic oculoplastic surgery. Curr. Opin. Ophthalmol.13(5), 324–330 (2002).
  • Foster JA, Wulc AE, Holck DE. Cosmetic indications for botulinum A toxin. Semin. Ophthalmol.13(3), 142–148 (1998).
  • Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology95(11), 1529–1534 (1988).
  • Edelstein C, Schorr J, Jacobs J et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol. Surg.24, 1208–1212 (1998).
  • Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles: dose and response. Dermatol. Surg.24, 1179–1180 (1998).
  • Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol. Surg.24, 1189–1194 (1998).
  • Carucci JA, Zweibel SM. Botulinum A exotoxin for rejuvenation of the upper third of the face. Facial Plast. Surg.17, 11–19 (2001).
  • Frankel AS, Kamer FM: Chemical browlift. Arch. Otolarygol. Head Neck Surg.124, 321–323 (1998).
  • Croes SA, Baryshnikova LM, Kaluskar SS, von Bartheld CS. Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles. Neurobiol. Dis.25(3), 649–664 (2007).
  • Godin MS, Majmundar MV, Chrzanowski DS, Dodson KM. Use of radiesse in combination with restylane for facial augmentation. Arch Facial Plast. Surg.8(2), 92–97 (2006).
  • Matarasso SL, Carruthers JD, Jewell ML; Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast. Reconstr. Surg.117(3 Suppl.), 3S–34S (2006).
  • McCracken MS, Khan JA, Wulc AE et al. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal. Plast. Reconstr. Surg.22(3), 188–191. (2006).
  • Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra), technical considerations in soft-tissue contouring. Plast. Reconstr. Surg.118(3 Suppl.), S55–S63 (2006).
  • Lowe NJ, Maxwell CA, Lowe P et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J. Am. Acad. Dermatol.45(6), 930–933 (2001).
  • Narins RS, Brandt F, Leyden J et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol. Surg.29(6), 588–595 (2003).
  • Soparkar CN, Patrinely JR, Tschen J. Erasing restylane. Ophthal. Plast. Reconstr. Surg.20(4), 317–318 (2004).
  • Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch. Facial Plast. Surg.7(4), 231–237 (2005).
  • Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol. Surg.32(2), 276–281 (2006).
  • Schanz S, Schippert W, Ulmer A et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br. J. Dermatol.146(5), 928–929 (2002).
  • Peter S, Mennel S. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane). Clin. Experiment Ophthalmol.34(4), 363–364 (2006).
  • McCord CD. Current trends in orbital decompression. Ophthalmology92, 21–33 (1985).
  • Goh MS, McNab AA. Orbital decompression in Graves’ orbitopathy: efficacy and safety. Intern. Med. J.35(10), 586–591 (2005).
  • Shorr N, Baylis HI, Goldberg RA, Perry JD. Transcaruncular approach to the medial orbit and orbital apex. Ophthalmology107(8), 1459–1463 (2000).
  • McCord CD Jr, Moses JL. Exposure of the inferior orbit with fornix incision and lateral canthotomy. Ophthalmic. Surg.10(6), 53–63 (1979).
  • Kennedy DW, Goodstein ML, Miller NR, Zinreich SJ. Endoscopic transnasal orbital decompression. Arch. Otolaryngol. Head Neck Surg.116, 275–282 (1990).
  • Walsh TE, Ogura JH. Transantral orbital decompression for malignant exophthalmos. Laryngoscope67, 544–549 (1957).
  • Trokel S, Kazim M, Moore S. Orbital fat removal: decompression for Graves’ orbitopathy. Ophthalmology100, 674–682.
  • Adenis JP, Robert PY, Lasudry JG, Dalloul Z. Treatment of proptosis with fat removal orbital decompression in Graves’ophthalmopathy. Eur. J. Ophthalmol.8(4), 246–252 (1998).
  • Leone CR, Piest KL Jr, Newman RJ. Medial and lateral wall decompression for thyroid ophthalmopathy. Am. J. Ophthalmol.108, 160–166 (1989).
  • Mouritis MP, Koorneef L, Wiersinga WM, et al. Orbital decompression for Graves’ ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology97, 636–641 (1990).
  • Unal M, Leri F, Konuk O, Hasanreisoglu B. Balanced orbital decompression combined with fat removal in Graves’ ophthalmopathy: do we really need to remove the third wall? Ophthal. Plast. Reconstr. Surg.19(2), 112–118.(2003).
  • Graham SM, Brown CL, Carter KD, Song A, Nerad JA. Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease. Laryngoscope113(7), 1206–1209 (2003).
  • Goldberg RA, Perry JD, Hortaleza V, Tong JT. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal. Plast. Reconstr. Surg.16(4), 271–277 (2000).
  • Ben Simon GJ, Wang L, McCann JD, Goldberg RA. Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome. Thyroid14(5), 379–383 (2004).
  • Ben Simon GJ, Syed HM, Lee S et al. Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated hess screen. Ophthalmology113(6), 1050–1055 (2006).
  • Garrity JA, Fatourechi V, Bergstralh EJ, et al. Results of transantral orbital decompression in 428 patients with severe Graves ophthalmopathy. Am J Ophthalmol116, 533–547 (1993).
  • Kikkawa DO, Pornpanich K, Cruz RC, Levi L, Granet DB. Graded orbital decompression based on severity of proptosis. Ophthalmology.109(7), 1219–1224 (2002).
  • Baldeschi L, MacAndie K, Hintschich C, Wakelkamp IM, Prummel MF, Wiersinga WM. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. Am. J. Ophthalmol.140(4), 642–647 (2005).
  • Goldberg RA. The evolving paradigm of orbital decompression surgery. Arch Ophthalmol.116(1), 95–96 (1998).
  • Siracuse-Lee DE, Kazim MD. Orbital decompression: current concepts. Curr. Opin. Ophthalmol.10, 310–316 (2002).
  • McCormick CD, Bearden WH, Hunts JH, Anderson RL. Cerebral vasospasm and ischemia after orbital decompression for graves ophthalmopathy. Ophthal. Plast. Reconstr. Surg.20(5), 347–51 (2004).
  • Kashkouli MB, Khalatbari MR, Falavarjani KG, Ghaleanovi H, Sanjari MS, Zaman B. Subarachnoid hemorrhage following uneventful thyroid orbital Decompression. Ophthal. Plast. Reconstr. Surg.23(4), 316–318. (2007).
  • McCord CD. Thyroid ophthalmopathy: compressive optic neuropathy. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme, NY, USA 315–326 (2001).
  • Vasconez LO, Gore GB, Gamboa-Bodadilla M, Guzman G, Askren C, Yamamoto Y. Endoscopic techniques in coronal brow lifting. Plast. Reconstr. Surg.94, 788 (1994).
  • Puig CM, LaFerriere KA. A retrospective comparison of open and endoscopic brow-lifts. Arch Facial Plast. Surg.4, 221–225 (2002).
  • Chiu E, Baker DC. Endoscopic brow lift: a retrospective review of 628 consecutive cases over 5 years. Plast. Reconstr. Surg.112, 628–633 (2003).
  • Chowdhury S, Malhotra R, Smith R, Arnstein P. Patient and surgeon experience the endotine forehead device for brow and forehead lift. Ophthal. Plast. Reconstr. Surg23(5), 358–362 (2007).
  • Berkowitz RL, Jacobs DI, Gorman PJ. Brow fixation with the Endotine Forehead device in endoscopic brow lift. Plast. Reconstr. Surg.116(6), 1761–1770 (2005).
  • Elkwood A, Matarasso A, Rankin M, Elkowitz M, Godek CP. National plastic surgery survey: brow lifting techniques and complications. Plast. Reconstr. Surg.108(7), 2143–2150 (2001).
  • Brazzo BG. Forehead lift. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 45–56 (2003).
  • Arneja JS, Larson DL, Gosain AK. Aesthetic and reconstructive brow lift: current techniques, indications, and applications. Ophthal. Plast. Reconstr. Surg.21(6), 405–411 (2005).
  • Booth AJ, Murray A, Tyers AG. The direct brow lift: efficacy, complications, and patient satisfaction. Br. J. Ophthalmol.88(5), 688–691 (2004).
  • Seiff SR. Management of orbital injuries. In: Oculoplastic surgery: the essentials. Chen WP (Ed.). Thieme NY, USA 475–488 (2001).
  • Waterhouse N, Lyne J, Urdang M, Garey L. An investigation into the mechanism of orbital blowout fractures. Br. J. Plast. Surg.52(8), 607–612 (1999).
  • Ahmad F, Kirkpatrick NA, Lyne J, Urdang M, Waterhouse N. Buckling and hydraulic mechanisms in orbital blowout fractures: fact or fiction? J. Craniofac. Surg.17(3), 438–441(2006).
  • Freeman LN, Seiff SR, Aguilar GL, Rathbun JE, Sullivan JH. Self-compression plates for orbital rim fractures. Ophthal. Plast. Reconstr. Surg.7(3), 198–207 (1991).
  • Cruz AA, Eichenberger GC. Epidemiology and management of orbital fractures. Curr. Opin. Ophthalmol.15(5), 416–421 (2004).
  • Wang BH, Robertson BC, Girotto JA et al. Traumatic optic neuropathy: A review of 61 patients. Plast. Reconstr. Surg.107(7), 1655–1664 (2001).
  • Tenzel RR, Miller GR. Orbital blow-out fracture repair, conjunctival approach. Am. J. Ophthalmol.71(5), 1141–2. (1971).
  • Heckler FR, Songcharoen S, Sultani FA. Subciliary incision and skin-muscle eyelid flap for orbital fractures. Ann. Plast. Surg.10(4), 309–313. (1983).
  • Holtmann B, Wray RC, Little AG. A randomized comparison of four incisions for orbital fractures. Plast. Reconstr. Surg.67(6), 731–737 (1981).
  • Werther, J. R. Cutaneous approaches to the lower lid and orbit. J. Oral Maxillofac. Surg.56(1), 60–65 (1998).
  • Millman AL, Della Rocca RC, Spector S, Leibeskind AL, Messina A. Steroids and orbital blowout fractures – a new systematic concept in medical management and surgical decision-making. Adv. Ophthalmic Plast. Reconstr. Surg.6, 291–300 (1987).
  • Yen MT, Anderson RL. Orbital fractures. In: Complications in ophthalmic plastic surgery. Brazzo BG (Ed.). Springer, NY, USA 241–254 (2003).
  • Stanley RB. Use of intraoperative computed tomography during repair of orbitozygomatic fractures. Arch. Facial Plast. Surg.1(1), 19–24 (1999).
  • Demianczuk AN, Antonyshyn OM. Application of a three-dimensional intraoperative navigational system in craniofacial surgery. J. Craniofac. Surg.8, 290 (1997).
  • Jin HR, Yeon JY, Shin SO, Choi YS, Lee DW. Endoscopic versus external repair of orbital blowout fractures. Otolaryngol Head Neck Surg.136(1), 38–44 (2007).
  • Mohadjer Y, Hartstein ME. Endoscopic orbital fracture repair. Otolaryngol. Clin. North Am.39(5), 1049–1057 (2006).
  • Rubin PA, Bilyk JR, Shore JW. Orbital reconstruction using porous polyethylene sheets. Ophthalmology101(10), 1697–708 (1994).
  • Ozturk S, Sengezer M, Isik S, Turegun M, Deveci M, Cil Y. Long-term outcomes of ultra-thin porous polyethylene implants used for reconstruction of orbital floor defects. J. Craniofac. Surg.16(6), 973–977 (2005).
  • Villarreal PM, Monje F, Morillo AJ, Junquera LM, González C, Barbón JJ. Porous polyethylene implants in orbital floor reconstruction. Plast. Reconstr. Surg.109(3), 877–885 (2002).
  • Zingg M, Laedrach K, Chen J et al. Classification and treatment of zygomatic fractures: a review of 1,025 cases. J. Oral Maxillofac. Surg.50(8), 778–790 (1992).
  • Gilhotra JS, McNab AA, McKelvie P, O’Donnell BA. Late orbital haemorrhage around alloplastic orbital floor implants: a case series and review. Clin. Experiment Ophthalmol.30(5), 352–355 (2002).
  • Bigham WJ, Stanley P, Cahill JM et al. Fibrovascular ingrowth in porous ocular implants: the effect of material composition, porosity, growth factors, and coatings. Ophthalmic Plast. Reconstr. Surg.15, 317–325 (1991).
  • Shields CL, Shields JA, DePotter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol.110, 333–338 (1992).
  • Custer PL, Kennedy RH, Woog JJ et al. Orbital implants in enucleation surgery: a report by the Am. Acad. Opthalmol. Ophthalmology110, 2054–2061 (2003).
  • Christmas NJ, Gordon CD, Murray TG et al. Intraorbital implants after enucleation and their complications: a 10-year review. Arch. Ophthalmol.116(9), 1199–1203 (1998).
  • Nunery WR, Heinz GW, Bonnin JM et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal. Plast. Reconstr. Surg.9(2), 96–104 (1993).
  • Trichopoulas N, Ausburger JJ. Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthal. Plast. Reconstr. Surg.21(5), 331–336 (2005).
  • Remulla HD, Rubin PA, Shore JW et al.Complications of porous spherical orbital implants. Ophthalmology102(4), 586–593 (1995).
  • Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthal. Plast. Reconstr. Surg.12(1), 18–31 (1996).
  • Goldberg MF. A simplified scleral graft technique for covering an exposed orbital implant. Ophthalmic. Surg.19(3), 206–211 (1988).
  • Kim YD, Goldberg RA, Shorr N, Steinsapir KD. Management of exposed hydroxyapatite orbital implants. Ophthalmology101(10), 1709–1715 (1994).
  • Massry GG, Holds JB, et al. Frontal periosteum as an exposed orbital implant cover. Ophthalmic Plast. Reconstr. Surg.106, 2091–2097 (1999).
  • Dolphin K. Enucleaion. In: Complications In Ophthalmic Plastic Surgery. Brazzo BG (Ed.). Springer, NY, USA, 233–240 (2003).
  • Guillinta P, Vasani SN, Granet DB, Kikkawa DO. Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophthal. Plast. Reconstr. Surg.19(2), 119–22 (2003).
  • Jordon DR, Chan S, Mawn L et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology106, 505–512 (1999).
  • Edelstein C, Shields CL, DePotter P et al. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology104, 1616–1620 (1997).
  • Colen TP , Paridaens DA, Lemij HG et al. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology107, 1889–1894 (1997).
  • Heinz GW, Nunery WR. Anophthalmic socket: evaluation and management. In: Oculoplastic Surgery. McCord CD (Ed.). Raven Press NY, USA 609–937 (1995).
  • Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr. Opin. Ophthalmol.11, 372–385 (2000).
  • Smit TJ, Koornneef L, Zonneveld FW, Groet E, Otto AJ. Computed tomography in the assessment of the postenucleation socket syndrome. Ophthalmology97(10), 1347–1351 (1990).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.